Noopur Raje - Publications, H-index & Citations

Noopur Raje

center for multiple myeloma

102H指数

1.0K论文数

4.4W被引数

收录论文 148

发表时间

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis 达拉妥木单抗、来那度胺和地塞米松在移植不适宜的新诊断多发性骨髓瘤中的应用：MAIA最终生存分析

Leukemia

IF13.4

2026-08-24

OAAI

Thierry Facon; Shaji K. Kumar; Robert Z. Orlowski; Nizar Bahlis; Philippe Moreau; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Sonja Zweegman; Katja Weisel; Aurore Perrot; Caroline Jacquet; Noopur Raje; Salomon Manier; Ajai Chari; Markus Hansson; Mohamad Mohty; Michel Delforge; Torben Plesner; Gordon Cook; Xavier Leleu; Hang Quach; Christopher P. Venner; Mourad Tiab; Margaret Macro; Laurent Frenzel; George Wang; Huiling Pei; Kasey Bolyard; Robin Carson; Fredrik Borgsten; Saad Z. Usmani

Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.高危及难治性多发性骨髓瘤患者接受BCMA CAR-T治疗后对新共识基因组分期（CGS）的验证与优化

Blood Cancer Journal

IF11.6

2026-04-22

OAAI

Joshua N. Gustine; Narsis Attar; Benjamin R. Puliafito; Diana D. Cirstea; Andrew R. Branagan; Andrew J. Yee; Noopur S. Raje

Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T 多发性骨髓瘤患者接受BCMA CAR-T治疗后血清学和PET/CT反应动力学的预后价值

Leukemia

IF13.4

2025-12-19

OAAI

Joshua N. Gustine; John A. Scaringi; Fabian Bauer; Diana D. Cirstea; Andrew R. Branagan; Benjamin R. Puliafito; Marcela V. Maus; Matthew J. Frigault; Andrew J. Yee; Umar Mahmood; Noopur S. Raje

Body Composition Metrics Associated with Time to Progression in Smoldering Multiple Myeloma 与进展时间相关的冒烟型多发性骨髓瘤的身体成分指标

Diagnostics 2025, Vol. 15, Page 2760

IF3.3

2025-10-31

OAAI

Fabian Bauer; Florian A. Huber; Marilyn E. Galdamez; Ivanna Zorgno; Sina Habibollahi; Amine El Kandoussi; Florian J. Fintelmann; P. Erik Tonnesen; Anna-Sophia W. Dietrich; Zhe Wang; Adam Graeber; Robert D. Boutin; Leon Lenchik; Joshua N. Gustine; Steven J. Staffa; Noopur Raje; Connie Y. Chang

Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy 心血管并发症及其与接受嵌合抗原受体T细胞疗法的多发性骨髓瘤患者短期和长期预后的关联

British Journal of Haematology

IF3.8

2025-10-19

PREAI

Osnat Itzhaki Ben Zadok; Panagiotis Simitsis; Caron Jacobson; Omar Nadeem; Matthew J. Frigault; Noopur Raje; Caitlyn Duffy; Patrick Costello; Jamie Dela Cruz; Andrew Looka; Anju Nohria

Efficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysis 骨改良药物在预防多发性骨髓瘤椎体并发症中的疗效：一项系统评价和荟萃分析

The Spine Journal

IF0

2025-10-14

PREAI

Zsombor T. Gal; Ethan A. Wetzel; Brian V. Nahed; Philip J. Saylor; Joshua A. Hirsch; Ariel E. Marciscano; Noopur S. Raje; Daniel G. Tobert; Andrew J. Yee; Ganesh M. Shankar

Vaccination during bispecific antibody treatment for myeloma 在双特异性抗体治疗多发性骨髓瘤期间接种疫苗

Blood Advances

IF7.1

2025-10-13

OAAI

Rahul Banerjee; Noopur S. Raje

Transdifferentiation from Multiple Myeloma to Myeloid Sarcoma in the Setting of CAR T-Cell Therapy 在CAR T细胞治疗背景下，多发性骨髓瘤向骨髓瘤肉瘤的转分化

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-10-09

PREAI

Diana Cirstea; Kathleen Gallagher; Maxx King; Paola Dal Cin; Mark J Sloan; Marcela V Maus; Noopur Raje; Matthew Frigault; Valentina Nardi

Radiation therapy to manage isolated relapse after chimeric antigen receptor T-cell therapy in multiple myeloma 针对多发性骨髓瘤中嵌合抗原受体T细胞疗法后孤立性复发的放射治疗

HAEMATOLOGICA

IF7.9

2025-10-01

OAAI

Srinivas, Surbhi; Zhu, Lin L.; Raje, Noopur; Patel, Chirayu G.

The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma 内源性T细胞景观被CAR-T细胞疗法重塑，并预测多发性骨髓瘤的治疗反应

Leukemia

IF13.4

2025-09-19

OAAI

Julia Frede; Julia C. Poller; Kayleen Shi; Hannah Stuart; Noori Sotudeh; Claire Havig; Klothilda Lim; Caroline R. M. Wiggers; Eugene Y. Cho; Tushara Vijaykumar; Jianlin Liu; Johannes M. Waldschmidt; Monica S. Nair; Praveen Anand; Valeriya Dimitrova; Anna Montanaro; Andrew J. Yee; Nikhil C. Munshi; Kenneth C. Anderson; Nathan Martin; Shari M. Kaiser; Marc-Steffen Raab; Noopur S. Raje; Birgit Knoechel; Jens G. Lohr

Bispecific T-cell engager therapy for multiple myeloma 双特异性T细胞接合剂疗法用于多发性骨髓瘤

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

IF0

2025-09-01

OAAI

Cirstea, Diana; Puliafito, Benjamin; Kim, Bridget E.; Lei, Matt; Raje, Noopur

IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels IVIG预防应在多发性骨髓瘤的双特异性抗体治疗后开始，无论IgG水平如何

Blood Advances

IF7.1

2025-07-23

OAAI

Rahul Banerjee; Meera Mohan; Kai Rejeski; Benjamin R. Puliafito; Diana D. Cirstea; Gurbakhash Kaur; Shonali Midha; Georgia J. McCaughan; Nikhil M. Kumar; Nikita Mehra; Bhausaheb Bagal; Noopur S. Raje

Psychosocial and NF-κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial 心理社会和NF-κB活性：压力管理与韧性训练（放松反应韧性计划，SMART-3RP）对MGUS和冒烟型多发性骨髓瘤患者的影响：一项随机等待列表对照试验

Psycho-Oncology

IF3.5

2025-07-18

PREAI

Lucy Finkelstein-Fox; John W. Denninger; Leah E. Walsh; Jacob P. Laubach; Andrew Jenho Yee; Elizabeth O'Donnell; Eric A. Macklin; Xuesong Gu; Alona Muzikansky; Towia A. Libermann; Gabriella Nicolosi; Paul G. Richardson; Noopur S. Raje; Gregory L. Fricchione; Giselle K. Perez; Lara N. Traeger; Emma Chad-Friedman; Elyse R. Park

Invasive Fungal Disease is Rare in Relapsed/Refractory Multiple Myeloma Patients Treated with BCMA CAR T-cell Therapy 侵袭性真菌疾病在经BCMA CAR T细胞治疗的复发/难治性多发性骨髓瘤患者中较为罕见。

Blood Advances

IF7.1

2025-06-27

OAAI

Jessica S. Little; Angelica Medina Pena; E. Bridget Kim; Andrew J. Yee; Omar Nadeem; Shonali Midha; Adam S. Sperling; Nikhil C. Munshi; Noopur Raje; Matthew J. Frigault; Diana D. Cirstea; Sarah P. Hammond

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia 多发性骨髓瘤和Waldenström巨球蛋白血症患者对SARS-CoV-2加强疫苗免疫原性的前瞻性研究

Blood Advances

IF7.1

2025-06-09

OAAI

Andrew R. Branagan; Clifton Mo; Matthew Lei; Joshua N. Gustine; Andrew J. Yee; Elizabeth O’Donnell; Jorge J. Castillo; Omar Nadeem; Catherine Flynn; Zachary Bernstein; Rie Nakamoto-Matsubara; Kirsten Meid; Rakesh Verma; Zachary R. Hunter; Maria L. Guerrera; Galit Alter; Jill Burke; Cynthia Harrington; Emerentia Agyemang; Marilyn Gammon; Kathleen Lively; Lisette Packer; Nora Horick; Jacob Laubach; Constantine S. Mitsiades; Nikhil Munshi; Kenneth C. Anderson; Steven P. Treon; Paul G. Richardson; Noopur S. Raje; Shayna R. Sarosiek

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury 早期达雷木单抗治疗可改善因肾脏损伤而入院的新诊断多发性骨髓瘤患者的肾脏结局

Blood Advances

IF7.1

2025-03-18

OAAI

E. Bridget Kim; Jack E. Malespini; Matthew Lei; Samuel S. Han; Cole W. Minsky; Andrew R. Branagan; Elizabeth K. O’Donnell; Diana Cirstea; Noopur S. Raje; Andrew J. Yee

Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma

BLOOD CANCER JOURNAL

IF11.6

2024-12-23

OAAI

Nakamoto-Matsubara, Rie; Nardi, Valentina; Horick, Nora; Fukushima, Tsuyoshi; Han, Ryan S.; Shome, Rajib; Ochi, Kiyosumi; Panaroni, Cristina; Fulzele, Keertik; Rexha, Farah; Branagan, Andrew R.; Cirstea, Diana; Yee, Andrew J.; Scadden, David T.; Raje, Noopur S.

Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy 接受嵌合抗原受体T细胞治疗的多发性骨髓瘤和淋巴瘤患者的心血管并发症及其与短期和长期预后的关系

CIRCULATION

IF38.6

2024-11-26

PREAI

Ben Zadok, Osnat Itzhaki; Simitsis, Panagiotis; Jacobson, Caron; Nadeem, Omar; Frigault, Matthew J.; Raje, Noopur; Duffy, Caitlyn; Costello, Patrick; Dela Cruz, Jamie; Looka, Andrew; Nohria, Anju

Improving reporting of infection events in clinical trials

BLOOD ADVANCES

IF7.1

2024-11-26

OAAI

Ludwig, Heinz; Munshi, Nikhil C.; Terpos, Evangelos; Raje, Noopur; Moreau, Philippe; Nooka, Ajay

Outcomes of Patients By High-Risk Cytogenetic Abnormalities in a Phase II Study of Isatuximab, Weekly Carfilzomib, Lenalidomide, Dexamethasone in Newly Diagnosed, Multiple Myeloma (The SKylaRk Trial) Who Deferred Transplant 伊沙妥昔单抗、每周卡非佐米、来那度胺、地塞米松方案在初诊多发性骨髓瘤患者（SKylaRk试验）中，因延迟移植的高风险细胞遗传学异常患者的结局

BLOOD

IF23.1

2024-11-05

PREAI

O'Donnell, Elizabeth K.; Mo, Clifton C.; Nadeem, Omar; Laubach, Jacob; Rosenblatt, Jacalyn; Munshi, Nikhil C.; Midha, Shonali; Cirstea, Diana; Richardson, Paul G.; Raje, Noopur; Yee, Andrew J.

研究方向